Organogenesis Holdings Inc. current report, 28 January 2019

Business Context and Reporting Period

This Form 8-K was filed by Organogenesis Holdings Inc. on January 28, 2019. The report addresses an amendment to the company's existing credit agreement and consent agreement involving its wholly owned subsidiaries, Organogenesis Inc. and Prime Merger Sub, LLC, with Silicon Valley Bank as the administrative agent.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt balances, or liquidity ratios. The document focuses exclusively on the modification of contractual deadlines and covenant testing dates rather than reporting financial performance data.

Material Changes

The primary material change is the execution of an Amendment to the Consent Agreement dated August 17, 2018. This amendment modifies the obligations under the Credit Agreement dated March 21, 2017, specifically regarding timing for financial deliverables and covenant compliance.

Guidance, Outlook, and Management Commentary

Management has secured extensions for key financial milestones under the Credit Agreement. The Amendment establishes the following new deadlines:

  • Projections and Financial Statements: Delivery deadline extended to February 15, 2019.
  • Updated Financial Covenants: Deadline for mutual agreement extended to March 8, 2019.
  • Covenant Testing Date: The next testing date for financial covenant levels extended to March 31, 2019.

The filing does not contain forward-looking guidance on revenue or earnings, nor does it detail specific risks or contingencies beyond the context of the credit agreement amendment.

Investor Verification Checklist

  • Verify the status of the financial projections and statements due by February 15, 2019.
  • Monitor the negotiation progress for updated financial covenants with a target agreement date of March 8, 2019.
  • Confirm compliance with the extended financial covenant testing date of March 31, 2019.
  • Review the full text of the Credit Agreement and Consent Agreement to understand the specific covenant thresholds being tested.